CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shock

Area of Science:

• Immunology
• Microbiology
• Biochemistry

Background:

• CD6 is a lymphocyte receptor within the scavenger receptor cysteine-rich superfamily.
• Some scavenger receptor superfamily members function as pattern recognition receptors for microbial components.

Purpose of the Study:

• To investigate whether CD6 possesses pattern recognition receptor activity for microbial components.
• To explore the potential therapeutic applications of CD6 in inflammatory diseases.

Main Methods:

• Production of recombinant CD6 ectodomain (rsCD6) and comparison with native CD6.
• Assessment of rsCD6 binding to Gram-positive and Gram-negative bacteria.
• Analysis of CD6-LPS interaction kinetics and downstream signaling (MAPK cascade).
• In vivo studies evaluating rsCD6 efficacy in a lipopolysaccharide (LPS)-induced septic shock mouse model.

Main Results:

• rsCD6 demonstrated binding and aggregation of various bacterial strains via recognition of lipoteichoic acid and LPS.
• The binding affinity of CD6 for LPS was comparable to CD14.
• Membrane CD6 exhibited LPS-binding ability, activating the MAPK signaling cascade.
• rsCD6 administration significantly improved survival in mice challenged with lethal LPS, reducing pro-inflammatory cytokine levels (TNF-alpha, IL-6, IL-1beta).

Conclusions:

• CD6 exhibits previously unrecognized bacterial binding properties.
• These findings suggest CD6 plays a role in innate immunity and microbial recognition.
• CD6 holds therapeutic potential for treating septic shock and other infectious inflammatory conditions.